###### 

Probability of virological failure in experienced patients treated with DRV/r-based Dual Therapy

                            HR      IC 95% Lower   IC 95% Upper   p value
  ------------------------- ------- -------------- -------------- ---------
  Male Gender               0.905   0.497          1.648          0.745
  Age (per year)            1.021   0.994          1.049          0.127
  IDU                       0.759   0.429          1.343          0.343
  Non Italian               1.390   0.485          3.983          0.540
  HIV non-subtype vs B      1.979   0.858          4.561          0.109
  HCV positivity            1.070   0.981          1.168          0.128
  N Previous Regimens       0.993   0.897          1.100          0.890
  N PI used                 1.062   0.928          1.214          0.382
  Und VL at Dual switch     3.022   1.696          5.720          \<0.001
  Baseline CD4              0.973   0.920          1.030          0.348
  CD4 nadir                 1.032   0.900          1.183          0.653
  Raltegravir               1                                     
  MAR (vs RAL)              1.372   0.673          2.797          0.385
  ETV (vs RAL)              1.157   0.473          2.831          0.750
  DRV 600 bid (vs 800 QD)   0.556   0.314          0.986          \<0.05
  GSS (REGA, each point)    0.595   0.400          0.884          \<0.01
